The present disclosure relates generally to controlled extension medical stents, and more particularly to controlled extension devices positioned in the body to stent the ureter and facilitate drainage from the kidney to the bladder.

Systems, devices, and methods are provided for the delivery of an implant into the prostatic urethra. Embodiments of delivery systems can include a delivery device for insertion into the patient and a proximal control device for use in controlling release of the implant from the delivery device.

Described herein are substrate coatings.

The present disclosure relates generally to the field of medical devices. In particular, the present disclosure relates to medical devices for facilitating the flow of fluids and materials in and/or between adjacent body lumens, for example, a stent which maintains an open flow passage between body lumens. In one example, a stent may have a constrained configuration and an expanded configuration. In the expanded configuration, the stent may have first and second retention members and saddle region extending therebetween. The saddle region may comprise a coil configured to apply a restoring force to tissue surfaces respectively apposed to the first and second retention members.

Methods for securing strand ends of devices configured for insertion into an anatomical structure, and the resulting devices.

Benign prosthetic hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland. Treatment options for BPH include medication, surgery (e.g., removal of enlarged prostate tissue), and minimally invasive procedures (e.g., needle ablation, electrovaporization, thermotherapy, and stent insertion). Minimally invasive procedure is typically the preferred choice if medication is ineffective. Accordingly, disclosed herein are system and method for treating BPH using improved implant and delivery device. Certain embodiments of the delivery device can include: a camming barrel having a first groove at the distal end of the camming barrel; a sheath, located within a lumen of the camming barrel, for storing the implantable device; and a first cam follower coupled to the sheath.

The present invention relates to an endoluminal device for implantation in a body lumen, such as a pancreatic duct. The device is provided with a distal end region having greater flexibility than that of a medial region of the device.

Systems, devices, and methods are provided for the delivery of an implant into the prostatic urethra. Embodiments of delivery systems can include a delivery device for insertion into the patient and a proximal control device for use in controlling release of the implant from the delivery device.

A medical stent having a first end, a second end, and a central longitudinal axis extending from the first end to the second end, may include a plurality of first filaments each extending in a first helical path around the central longitudinal axis in a first direction and a plurality of second filaments each extending in a second helical path around the central longitudinal axis in a second direction. The plurality of first filaments may be interwoven with the plurality of second filaments. The first helical path of at least one of the plurality of first filaments may include a circumferential offset disposed between the first end and the second end.

The stent has an expansive force 0.05 N/mm or less per unit length when it has a diameter equal to the lower limit diameter of the target blood vessel and is measured under the following conditions. A radial force testing system manufactured by Blockwise Engineering LLC is used as a tester. The test conditions include a temperature of 37° C.±2° C. in the chamber of the tester; a stent diameter of 0.5 mm for start of test, and a rate of increase of diameter of 0.5 mm/s in the tester. The test method includes radially compressing the stent disposed in the chamber; recording an expansive force while gradually increasing the diameter of the chamber at the rate of increase of diameter; and dividing the expansive force by the effective length of the stent to calculate an expansive force per unit length.